Here is a comprehensive overview of dysentery medications, covering the two main types — bacillary dysentery (Shigella) and amebic dysentery — based on authoritative medical textbooks.
Dysentery: Overview of Treatment
1. Bacillary Dysentery (Shigellosis)
Caused by Shigella species, including S. dysenteriae type 1 (the most severe).
General principles:
- Mild, uncomplicated cases in high-income settings may be self-limiting and require no antibiotic treatment
- Oral rehydration (with zinc sulfate 20 mg) is the cornerstone of supportive care
- Antimotility agents (e.g., loperamide) are contraindicated — they prolong symptoms and bacterial shedding
- Antibiotics are routinely recommended for dysentery (bloody diarrhea with fever), severe illness, immunocompromised patients, and during outbreaks
Antibiotic regimens (WHO-recommended):
| Drug | Children | Adults | Notes |
|---|
| Ciprofloxacin (first-line) | 15 mg/kg twice daily × 3 days PO | 500 mg once daily × 3 days PO | Fluoroquinolone of choice |
| Ceftriaxone (severe/IV) | 50–100 mg/kg once daily × 2–5 days IV/IM | 1 g every 24 h × 3 days IV/IM | For vomiting, unconsciousness, or severe illness |
| Azithromycin (if cipro-resistant) | 6–20 mg/kg once daily × 1–5 days PO | 500 mg twice daily × 1 day (or 1–1.5 g) | Risk of resistance emergence |
| Pivmecillinam (second-line) | 20 mg/kg 4×/day × 5 days PO | 100 mg 4×/day × 5 days | Limited by frequent dosing and cost |
| TMP-SMX (where susceptible) | — | 160/800 mg twice daily × 5 days | Resistance increasingly common |
| Cefixime (oral alternative) | — | 400 mg once daily × 3 days | For cipro-resistant strains |
Duration notes:
- Non-dysenteriae Shigella in immunocompetent adults: 3 days
- S. dysenteriae type 1: 5 days
- Immunocompromised patients: 7–10 days
— Goldman-Cecil Medicine, Harrison's Principles of Internal Medicine 22E
2. Amebic Dysentery (Entamoeba histolytica)
Treatment of choice: Metronidazole + a luminal amebicide
Tissue/Invasive Amebicides (treat colitis and systemic disease)
| Drug | Role | Notes |
|---|
| Metronidazole | First-line; kills trophozoites | 500–750 mg three times daily × 7–10 days; does NOT kill cysts |
| Tinidazole | Alternative to metronidazole | Simpler dosing, better tolerability; same mechanism |
| Tetracyclines | Alternative for moderate colitis only | Not effective against extraintestinal disease |
| Erythromycin | Alternative for moderate colitis only | Not effective against extraintestinal disease |
Mechanism of metronidazole/tinidazole: The nitro group is chemically reduced in anaerobic organisms, generating reactive products responsible for antiprotozoal activity. Both drugs are well absorbed orally, with low protein binding; metronidazole half-life ~7.5 h, tinidazole ~12–14 h.
Luminal Amebicides (must always be added to eradicate cysts in the gut)
| Drug | Efficacy |
|---|
| Diloxanide furoate | ~80–90% eradication of carriage |
| Iodoquinol | ~80–90% eradication of carriage |
| Paromomycin | ~80–90% eradication of carriage |
Important: Even after successful treatment of invasive disease with metronidazole, a luminal amebicide must be added — metronidazole and tinidazole do not reliably eliminate luminal cysts.
— Goldman-Cecil Medicine, Katzung's Basic and Clinical Pharmacology 16th Ed.
3. Other Causes of Dysentery-Like Illness
| Organism | Treatment |
|---|
| Trichuris trichiura (whipworm) | Mebendazole, albendazole, or ivermectin |
| Balantioides coli | Tetracycline or metronidazole |
| EIEC (E. coli invasive) | Supportive; antibiotics generally not recommended (risk of HUS) |
Key Clinical Pearls
- Resistance is rising for Shigella — always use local susceptibility data when available
- Do not use antimotility agents in dysentery
- Zinc supplementation (20 mg/day × 10–14 days) reduces duration of shigellosis in children in resource-limited settings
- For amebic liver abscess (complication of amebic dysentery): metronidazole × 10 days cures >95% of uncomplicated cases; if metronidazole fails, add chloroquine and consider abscess aspiration